New malaria analysis method reveals disease severity in minutes

August 11, 2017
Red blood cells become less deformable as they undergo heme-induced oxidative stress caused by malaria parasites. Credit: Kerryn Matthews, University of British Columbia

Left untreated, malaria can progress from being mild to severe—and potentially fatal—in 24 hours. So researchers at the University of British Columbia developed a method to quickly and sensitively assess the progression of the mosquito-borne infectious disease, which remains a leading killer in low-income countries.

One way wreaks havoc on the body is by causing excessive amounts of toxic heme, the non-protein component of hemoglobin, to accumulate in the bloodstream. Among other things, this free heme induces in (RBCs), leading to their rigidification, destruction and subsequent removal from circulation—a condition known as hemolytic anemia.

In their study, which appeared in Integrative Biology, the UBC investigators found that RBCs become increasingly rigid in direct correlation with the concentration of oxidized heme, or hemin, in the blood. Since hemin is difficult to measure directly—it tends to insert itself into cell membranes—monitoring changes in RBC deformability can therefore serve as a reliable alternative marker of hemin-induced oxidative stress and malaria progression.

"Because this method is mechanical, it's well suited for use in resource-poor countries, where the vast majority of malaria transmission takes place," says Kerryn Matthews, a postdoctoral fellow at UBC and the study's lead author. "Other methods of analyzing malaria severity require training or expensive equipment or chemicals that are not readily available in developing nations."

To measure RBC deformability quickly and sensitively, the UBC investigators developed the "multiplex fluidic plunger": a simple microfluidic device consisting of a parallel array of 34 funnel-shaped, micro-sized channels across which uniform, carefully controlled pressures can be simultaneously applied.

By loading the plunger with whole blood, docking an RBC at each channel and applying progressively higher pressures until the RBCs are squeezed through—or not, if an RBC is too stiff—one is able to determine the rigidity, or cortical tensions, of many cells at once and build an RBC deformability profile in minutes.

"The device can be easily integrated with a conventional microscope coupled with a digital camera," says Matthews. "And the accompanying software, which does all the analysis and records the pressures, is simple to use."

In addition to indicating the status of a malaria infection, RBC deformability information would be valuable in the development of antimalarial drugs, as well as in illuminating the mechanism by which RBCs are sequestered from circulation and destroyed.

Healthy RBCs are extremely flexible, capable of squeezing through spaces—the tiniest blood vessels, for example, or the channels between cells—that are just fractions of their original size. By rendering them less deformable, malaria parasites impair flow and ultimately cause organ failure and possibly death.

According to the World Health Organization, malaria killed an estimated 429,000 people and caused approximately 212 million clinical episodes in 2015. It primarily affects children and pregnant women in poor tropical and subtropical countries.

Explore further: Quantitative assessment of dynamic deformability and adhesion of red blood cells possible

More information: Kerryn Matthews et al, Microfluidic analysis of red blood cell deformability as a means to assess hemin-induced oxidative stress resulting from Plasmodium falciparum intraerythrocytic parasitism, Integr. Biol. (2017). DOI: 10.1039/c7ib00039a

Related Stories

Quantitative assessment of dynamic deformability and adhesion of red blood cells possible

March 1, 2016
A team of researchers from the Case Western Reserve University (CWRU) in Cleveland, OH have developed a versatile microfluidic platform integrated with a cell dimensioning algorithm for quantitative assessment of dynamic ...

Researcher invents 'lab on a chip' device to study malaria

February 28, 2012
University of British Columbia researcher Hongshen Ma has developed a simple and accurate device to study malaria, a disease that currently affects 500 million people per year worldwide and claims a million lives.

Malaria-infected cells may latch onto healthy blood cells for protection

November 5, 2014
The distinctive 'clumping' of blood cells that blocks vessels and causes tissue damage in malaria-infected patients is the focus of a multinational collaboration, which includes A*STAR researchers.

Recommended for you

How hepatitis C hides in the body

October 13, 2017
The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus ...

Largest study yet of malaria in Africa shows historical rates of infection

October 12, 2017
(Medical Xpress)—A team of researchers with members from the Kenya Medical Research Institute, the University of Oxford and the University of KwaZulu-Natal has conducted the largest-ever study of the history of malaria ...

Promising new target for treatment of psoriasis is safe, study shows

October 11, 2017
A protein known to play a significant role in the development of psoriasis can be prevented from functioning without posing a risk to patients, scientists at King's College London have found.

Norovirus evades immune system by hiding out in rare gut cells

October 11, 2017
Noroviruses are the leading cause of non-bacterial gastroenteritis in the world and are estimated to cause 267 million infections and 20,000 deaths each year. This virus causes severe diarrhea, nausea, and stomach pain.

Research reveals how rabies can induce frenzied behavior

October 11, 2017
Scientists may finally understand how the rabies virus can drastically change its host's behavior to help spread the disease, which kills about 59,000 people annually.

Experimental Ebola vaccines elicit year-long immune response

October 11, 2017
Results from a large randomized, placebo-controlled clinical trial in Liberia show that two candidate Ebola vaccines pose no major safety concerns and can elicit immune responses by one month after initial vaccination that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.